Infliximab-induced skin manifestations in patients with inflammatory bowel disease
Author:
Affiliation:
1. Helsinki University Hospital, Clinic of Gastroenterology, University of Helsinki, Helsinki, Finland;
2. Helsinki University Hospital, Children’s Hospital and Helsinki University, Helsinki, Finland
Funder
Lastentautien Tutkimussäätiö
Sigrid Juséliuksen Säätiö
Publisher
Informa UK Limited
Subject
Gastroenterology
Link
https://www.tandfonline.com/doi/pdf/10.3109/00365521.2015.1125524
Reference33 articles.
1. The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management
2. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management
3. The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD With the European Crohn's and Colitis Organisation: Safety
4. Dermatological adverse reactions during anti-TNF treatments: Focus on inflammatory bowel disease
5. Skin Reactions During Anti-TNFα Therapy for Pediatric Inflammatory Bowel Disease
Cited by 39 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Dermal lesions associated with anti-tumor necrosis factor-α therapy in patients with inflammatory bowel disease: findings from an inflammatory bowel disease tertiary center in Poland;Polish Archives of Internal Medicine;2024
2. A Case of Paradoxical Reactions to Biologic Therapy for Psoriasis;Clinical, Cosmetic and Investigational Dermatology;2023-06
3. Anti‐tumour necrosis factor‐induced skin rashes in inflammatory bowel disease: a systematic review and evidence‐based management algorithm;Internal Medicine Journal;2022-09-30
4. A Review of Extraintestinal Manifestations & Medication-Induced Myocarditis and Pericarditis in Pediatric Inflammatory Bowel Disease;Cureus;2022-06-27
5. Outcomes of Children with Inflammatory Bowel Disease who Develop Anti-tumour Necrosis Factor-induced Skin Reactions;Journal of Crohn's and Colitis;2022-04-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3